From October 16th to 18th 2019 we have attended the 64th EUHA (European Association of Hearing Acousticians) congress in Nuremberg, Germany. With more than 8’000 participants, 140 exhibitors and 20 expert lectures the EUHA congress is among the largest in the world in this field.
For the major hearing aid manufacturers, the focus this year was on form factor or category additions to existing platforms rather than new launches (Sivanto’s “Xperience” being the exception). With current platform cycles of 2 to 3 years, this was highly expected, as the current technology platforms in place are relatively young in age (Widex Evoke launched in April 2018 and being the oldest in the peer group).
After weeks of containment efforts, some governments dip their toe into the uncertain waters of re-opening parts of the economy. What needs to be in place in order to get back to a certain state of normalcy? And how does testing help in this endeavour?
As the world grapples with the outbreak of SARS-CoV-2 and people across the world experience dramatic cuts to their freedom of movement, the healthcare sector is racing to find solutions to tackle the current pandemic. How quickly could treatments for COVID-19 realistically become available?
We attended the 9th Annual SVB Leerink Global Healthcare Conference in New York from February 25 to 27, 2020, which hosted over 200 healthcare companies. As the spread of COVID-19 hit the markets this week, it was also the number one topic at the conference.